Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million

Abeona Therapeutics® Announces Option Exercise by Beacon Therapeutics for Novel AAV204 Capsid for Ophthalmology Gene Therapy

Jefferies Global Healthcare Conference

Jun 4, 2025 • 11:40am EDT

Annual Meeting of Stockholders

May 19, 2025 • 9:00am EDT